Article citationsMore>>

Borghaei, H., Paz Ares, L., Horn, L., Spigel, D.R., Steins, M., Ready, N.E., Chow, L.Q., Vokes, E.E., Felip, E., Holgado, E., Barlesi, F., kohlhaufl, M., Arrieta, O., Burgio, M.A., Fayette, J., Lena, H., Poddubskaya, E., Gerber, D.E., Gettinger, S.N., Rudin, C.M., Rizyi, N., Crino, L., Blumenschein Jr., G.R., Antonia, S.J., Dorange, C., Harbison, C.T., Finckenstein, F.G. and Brahmer, J.R. (2015) Nivolumab versus Docetaxel in Advanced Non Squamous Non Small Cell Lung Cancer. The New England Journal of Medicine, 373, 1627-1639.
https://doi.org/10.1056/NEJMoa1507643

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.
Top